UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response

Journal of allergy and clinical immunology, 2014-08, Vol.134 (2), p.362-372

2014

Link zum Volltext

Verfügbarkeit prüfen

Patterns of treatment with everolimus exemestane in hormone receptor-positive HER2-negative metastatic breast cancer in the era of targeted therapy

Breast cancer research : BCR, 2021-01, Vol.23 (1), p.14-14, Article 14

2021

Link zum Volltext

Verfügbarkeit prüfen

RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications

Journal of allergy and clinical immunology, 2015-05, Vol.135 (5), p.1218-1227

2015

Link zum Volltext

Verfügbarkeit prüfen

Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection

Journal of allergy and clinical immunology, 2015-01, Vol.135 (1), p.153-163

2015

Link zum Volltext

Verfügbarkeit prüfen

Comparison of PD-L1 protein expression between primary tumors and metastatic lesions in triple negative breast cancers

Journal for immunotherapy of cancer, 2020-11, Vol.8 (2), p.e001558

2020

Link zum Volltext

Verfügbarkeit prüfen

Optimal Management for Residual Disease Following Neoadjuvant Systemic Therapy

Current treatment options in oncology, 2021-09, Vol.22 (9), p.79, Article 79

2021

Link zum Volltext

Verfügbarkeit prüfen

Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod

Scientific reports, 2019-06, Vol.9 (1), p.8572-8572, Article 8572

2019

Link zum Volltext

Verfügbarkeit prüfen

Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology

Journal of allergy and clinical immunology, 2014-06, Vol.133 (6), p.1626-1634

2014

Link zum Volltext

Verfügbarkeit prüfen

Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin

Journal of allergy and clinical immunology, 2015-03, Vol.135 (3), p.712-720

2015

Link zum Volltext

Verfügbarkeit prüfen

Molecular differences between younger versus older ER-positive and HER2-negative breast cancers

NPJ breast cancer, 2022-11, Vol.8 (1), p.119-119, Article 119

2022

Link zum Volltext

Verfügbarkeit prüfen

Residual genomic profile after cyclosporine treatment may offer insights into atopic dermatitis reoccurrence

Journal of allergy and clinical immunology, 2014-10, Vol.134 (4), p.955-957

2014

Link zum Volltext

Verfügbarkeit prüfen

Changes in Pathological Complete Response Rates after Neoadjuvant Chemotherapy for Breast Carcinoma over Five Years

Journal of Oncology, 2016-01, Vol.2016, p.4324863-5

2016

Link zum Volltext

Verfügbarkeit prüfen

Somatic mutations in tumor-adjacent normal breast tissue in young women with high risk family history

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.576-576

2023

Link zum Volltext

Verfügbarkeit prüfen

The correlation of ESR1 genetic aberrations with estrogen receptor and progesterone receptor status in metastatic and primary estrogen receptor-positive breast carcinomas

Human pathology, 2023-07, Vol.137, p.56-62

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-19-12: Patterns of treatment with everolimus and exemestane in hormone receptor positive HER2 negative metastatic breast cancer in the era of targeted therapy

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P1-P1-19-12

2020

Link zum Volltext

Verfügbarkeit prüfen

New biologics for psoriasis and psoriatic arthritis

Dermatologic therapy, 2009-01, Vol.22 (1), p.56-60

2009

Link zum Volltext

Verfügbarkeit prüfen

Abstract PS19-05: Functional importance of long-tail mutations in breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS19-05-PS19-05

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract P3-07-01: Young women with breast cancer and high risk family history but no high penetrance germline mutations have a higher load of rare high functional impact germline variants in cancer relevant genes

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P3-P3-07-01

2022

Link zum Volltext

Verfügbarkeit prüfen

Trends in breast cancer death by stage at diagnoses in 2000-2018

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e18855-e18855

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract PS5-08: Comparison of PD-L1 protein expression between primary tumors and metastatic lesions in triple negative breast cancers

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS5-08-PS5-08

2021

Link zum Volltext

Verfügbarkeit prüfen

Molecular Characterization of HER2-Low Invasive Breast Carcinoma by Quantitative RT-PCR Using Oncotype DX Assay

The oncologist (Dayton, Ohio), 2023-10, Vol.28 (10), p.e973-e976

2023

Link zum Volltext

Verfügbarkeit prüfen

Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer

Clinical cancer research, 2022-06, Vol.28 (12), p.2587-2597

2022

Link zum Volltext

Verfügbarkeit prüfen

Sacituzumab govitecan: ascending the treatment algorithm in triple negative breast cancer

Annals of translational medicine, 2022-04, Vol.10 (7), p.390-390

2022

Link zum Volltext

Verfügbarkeit prüfen

Cancer Relevance of Human Genes

JNCI : Journal of the National Cancer Institute, 2022-07, Vol.114 (7), p.988-995

2022

Link zum Volltext

Verfügbarkeit prüfen

Targetable genomic mutations in young women with advanced breast cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.1027-1027

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(42)
Buchkapitel
(1)

Sprache

Englisch
(43)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response

Patterns of treatment with everolimus exemestane in hormone receptor-positive HER2-negative metastatic breast cancer in the era of targeted therapy

RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications

Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection

Comparison of PD-L1 protein expression between primary tumors and metastatic lesions in triple negative breast cancers

Optimal Management for Residual Disease Following Neoadjuvant Systemic Therapy

Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod

Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology

Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin

Molecular differences between younger versus older ER-positive and HER2-negative breast cancers

Residual genomic profile after cyclosporine treatment may offer insights into atopic dermatitis reoccurrence

Changes in Pathological Complete Response Rates after Neoadjuvant Chemotherapy for Breast Carcinoma over Five Years

Somatic mutations in tumor-adjacent normal breast tissue in young women with high risk family history

The correlation of ESR1 genetic aberrations with estrogen receptor and progesterone receptor status in metastatic and primary estrogen receptor-positive breast carcinomas

Abstract P1-19-12: Patterns of treatment with everolimus and exemestane in hormone receptor positive HER2 negative metastatic breast cancer in the era of targeted therapy

New biologics for psoriasis and psoriatic arthritis

Abstract PS19-05: Functional importance of long-tail mutations in breast cancer

Abstract P3-07-01: Young women with breast cancer and high risk family history but no high penetrance germline mutations have a higher load of rare high functional impact germline variants in cancer relevant genes

Trends in breast cancer death by stage at diagnoses in 2000-2018

Abstract PS5-08: Comparison of PD-L1 protein expression between primary tumors and metastatic lesions in triple negative breast cancers

Molecular Characterization of HER2-Low Invasive Breast Carcinoma by Quantitative RT-PCR Using Oncotype DX Assay

Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer

Sacituzumab govitecan: ascending the treatment algorithm in triple negative breast cancer

Cancer Relevance of Human Genes

Targetable genomic mutations in young women with advanced breast cancer

Suchergebnisse filtern